Supplemental Bioreactor Capacity Accelerates Bioprocess Development

When up against aggressive development timelines and technical milestones, access to additional methods of generating bioprocessing data can significantly accelerate the speed of drug development. This case study describes a successful collaboration between Cytovance Biologics and Culture Biosciences, where fermentation process was transferred, downscaled, modified and improved via a Design of Experiment (DoE), then verified and transferred back to Cytovance Biologics in just a few experiments.

Download to learn how Cytovance Biologics:

• expanded their internal capacity working with Culture's on-demand Cloud Bioreactor Lab
• increased their titer two-fold over the course of six experimental runs